ZA200711025B - N-dihydroxyalkyl-substituted 2-oxoimidazole derivative - Google Patents

N-dihydroxyalkyl-substituted 2-oxoimidazole derivative

Info

Publication number: ZA200711025B
Authority: ZA; South Africa
Prior art keywords: oxoimidazole; dihydroxyalkyl; derivative; substituted; oxoimidazole derivative
Prior art date: 2005-07-13

Application number

ZA200711025A

Other languages

English (en)

Inventor

Hashimoto Masaya

Kawamoto Hiroshi

Ozaki Satoshi

Sakoh Hiroki

Iwasawa Yoshikazu

Ohta Hisashi

Sagara Takeshi

Satoh Atsushi

Original Assignee

Banyu Pharma Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-07-13

Filing date

2007-12-19

Publication date

2008-12-31

2007-12-19 Application filed by Banyu Pharma Co Ltd filed Critical Banyu Pharma Co Ltd

2008-12-31 Publication of ZA200711025B publication Critical patent/ZA200711025B/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Psychology (AREA)
Urology & Nephrology (AREA)
Addiction (AREA)
Vascular Medicine (AREA)
Obesity (AREA)
Hematology (AREA)
Hospice & Palliative Care (AREA)
Child & Adolescent Psychology (AREA)
Diabetes (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

ZA200711025A 2005-07-13 2007-12-19 N-dihydroxyalkyl-substituted 2-oxoimidazole derivative ZA200711025B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP2005204264		2005-07-13

Publications (1)

Publication Number	Publication Date
ZA200711025B true ZA200711025B (en)	2008-12-31

Family

ID=37637260

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200711025A ZA200711025B (en)	2005-07-13	2007-12-19	N-dihydroxyalkyl-substituted 2-oxoimidazole derivative

Country Status (23)

Country	Link
EP (1)	EP1914232B1 (xx)
JP (1)	JP4748162B2 (xx)
KR (1)	KR20080033262A (xx)
CN (1)	CN101223158B (xx)
AR (1)	AR054816A1 (xx)
AU (1)	AU2006267391B2 (xx)
BR (1)	BRPI0613109A2 (xx)
CA (1)	CA2614688A1 (xx)
CR (1)	CR9692A (xx)
DE (1)	DE602006018950D1 (xx)
DO (1)	DOP2006000165A (xx)
EC (1)	ECSP088096A (xx)
ES (1)	ES2355580T3 (xx)
IL (1)	IL188418A0 (xx)
MA (1)	MA29738B1 (xx)
NI (1)	NI200800003A (xx)
NO (1)	NO20080770L (xx)
NZ (1)	NZ565026A (xx)
PE (1)	PE20070176A1 (xx)
RU (1)	RU2414456C2 (xx)
TW (1)	TW200740436A (xx)
WO (1)	WO2007007890A1 (xx)
ZA (1)	ZA200711025B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2008297524A1 (en) *	2007-09-11	2009-03-19	Mondobiotech Laboratories Ag	Use of Thymopentin as a therapeutic agent
US20100184675A1 (en) *	2007-09-11	2010-07-22	Dorian Bevec	Use of glucagon (1-29) alone or in combination with neuropeptide w30 as a therapeutic agent
PH12012502300A1 (en)	2010-05-27	2013-02-04	Targacept Inc	Nicotinic receptor non-competitive antagonists
DK3345907T3 (da) *	2015-09-01	2020-06-22	Taiho Pharmaceutical Co Ltd	Pyrazolo[3,4-d]pyrimidinforbindelser eller salte deraf
KR20240022630A (ko) *	2021-07-14	2024-02-20	이창 휴먼웰 파마슈티칼 코포레이션, 리미티드	피페리딘 유도체 및 그 약물 조성물, 제조 방법과 용도

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0786997A4 (en) *	1994-10-27	1998-03-11	Merck & Co Inc	MUSCARINE ANTAGONISTS
EP0898568B1 (en) *	1996-04-19	2006-10-04	Neurosearch A/S	1-(4-piperidyl)-benzimidazoles having neurotrophic activity
EP0990653B1 (en) *	1997-05-30	2004-09-15	Banyu Pharmaceutical Co., Ltd.	2-oxoimidazole derivatives
JP3342478B2 (ja) *	1998-01-19	2002-11-11	ファイザー製薬株式会社	Ｏｒｌ１−レセプターアゴニストとしての４−（２−ケト−１−ベンズイミダゾリニル）ピペリジン化合物
ID29137A (id) *	1998-07-27	2001-08-02	Schering Corp	Ligan-ligan afinitas tinggi untuk reseptor nosiseptin orl-1
US7456198B2 (en) *	1999-12-06	2008-11-25	Purdue Pharma L.P.	Benzimidazole compounds having nociceptin receptor affinity
RU2265018C2 (ru) *	2001-04-18	2005-11-27	Эро-Селтик, С.А.	Производные бензимидазола и фармацевтические композиции на их основе

2006
- 2006-07-04 AR ARP060102875A patent/AR054816A1/es not_active Application Discontinuation
- 2006-07-05 TW TW095124503A patent/TW200740436A/zh unknown
- 2006-07-10 PE PE2006000816A patent/PE20070176A1/es not_active Application Discontinuation
- 2006-07-11 KR KR1020087000923A patent/KR20080033262A/ko not_active Ceased
- 2006-07-11 NZ NZ565026A patent/NZ565026A/en not_active IP Right Cessation
- 2006-07-11 BR BRPI0613109-3A patent/BRPI0613109A2/pt not_active IP Right Cessation
- 2006-07-11 CA CA002614688A patent/CA2614688A1/en not_active Abandoned
- 2006-07-11 WO PCT/JP2006/314122 patent/WO2007007890A1/ja not_active Ceased
- 2006-07-11 JP JP2007524723A patent/JP4748162B2/ja not_active Expired - Fee Related
- 2006-07-11 DE DE602006018950T patent/DE602006018950D1/de active Active
- 2006-07-11 EP EP06781147A patent/EP1914232B1/en active Active
- 2006-07-11 AU AU2006267391A patent/AU2006267391B2/en not_active Ceased
- 2006-07-11 RU RU2008105396/04A patent/RU2414456C2/ru not_active IP Right Cessation
- 2006-07-11 ES ES06781147T patent/ES2355580T3/es active Active
- 2006-07-11 CN CN2006800256149A patent/CN101223158B/zh not_active Expired - Fee Related
- 2006-07-12 DO DO2006000165A patent/DOP2006000165A/es unknown
2007
- 2007-12-19 ZA ZA200711025A patent/ZA200711025B/xx unknown
- 2007-12-25 IL IL188418A patent/IL188418A0/en unknown
2008
- 2008-01-04 NI NI200800003A patent/NI200800003A/es unknown
- 2008-01-10 EC EC2008008096A patent/ECSP088096A/es unknown
- 2008-01-25 CR CR9692A patent/CR9692A/es unknown
- 2008-02-11 MA MA30637A patent/MA29738B1/fr unknown
- 2008-02-12 NO NO20080770A patent/NO20080770L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
AU2006267391B2 (en)	2011-12-08
CN101223158A (zh)	2008-07-16
PE20070176A1 (es)	2007-03-09
ES2355580T3 (es)	2011-03-29
EP1914232B1 (en)	2010-12-15
JPWO2007007890A1 (ja)	2009-01-29
DOP2006000165A (es)	2007-02-28
EP1914232A4 (en)	2009-10-28
DE602006018950D1 (de)	2011-01-27
BRPI0613109A2 (pt)	2012-12-04
IL188418A0 (en)	2008-11-03
NZ565026A (en)	2010-09-30
RU2008105396A (ru)	2009-08-20
JP4748162B2 (ja)	2011-08-17
NO20080770L (no)	2008-04-11
CN101223158B (zh)	2013-01-09
CR9692A (es)	2008-02-21
RU2414456C2 (ru)	2011-03-20
TW200740436A (en)	2007-11-01
EP1914232A1 (en)	2008-04-23
NI200800003A (es)	2008-07-21
AR054816A1 (es)	2007-07-18
AU2006267391A1 (en)	2007-01-18
ECSP088096A (es)	2008-02-20
WO2007007890A1 (ja)	2007-01-18
KR20080033262A (ko)	2008-04-16
CA2614688A1 (en)	2007-01-18
MA29738B1 (fr)	2008-09-01

Publication	Publication Date	Title
EP1942105A4 (en)	2011-06-15	AMINODIHYDROTHIAZINE DERIVATIVE
EP1878727A4 (en)	2013-11-13	2-AMINOQUINAZOLINE DERIVATIVES
ZA200707358B (en)	2009-08-26	1-benzylindole-2-carboxamide derivatives
IL192092A0 (en)	2008-12-29	Aryl-isoxazolo-4-yl-oxadiazole derivatives
DE502006001600D1 (en)	2008-10-30	Pyrazolylcarboxanilide
DE602006017073D1 (en)	2010-11-04	Aspartylproteasehemmer
HUS2000022I1 (hu)	2020-07-28	Tiglien-3-on származékok
ZA200802088B (en)	2008-11-26	4-Phenyl-6-substitued-pyrimidine-2-carbonitrile derivatives
ZA200802421B (en)	2009-01-28	1-Acyldihydropyrazol derivatives
ZA200804257B (en)	2009-04-29	Azaindole-2-carboxamide derivatives
IL184841A0 (en)	2007-12-03	Substituted aminoalkyl-and amidoalkyl-benzopyran derivatives
ZA200805353B (en)	2009-10-28	Aryl-isoxazol-4-yl-imidazole derivatives
EP1871379A4 (en)	2010-06-02	CYANOARYLAMINE
IL191138A0 (en)	2008-12-29	Pyrazoloisoquinoline derivatives
ZA200800365B (en)	2009-05-27	Substituted tetrahydroqulnolines
IL186107A0 (en)	2008-01-20	Pyridylmethylsulfone derivative
ZA200711025B (en)	2008-12-31	N-dihydroxyalkyl-substituted 2-oxoimidazole derivative
EP1871655A4 (en)	2012-12-26	TRIGGER OPERATION FOR SIDE DRIVE
EP1865780A4 (en)	2011-04-27	MINI OVEN
GB0511410D0 (en)	2005-07-13	Benzotrizepinone derivatives
ZA200706577B (en)	2010-02-24	Dihydroimidazothiazole derivatives
DE602006015303D1 (en)	2010-08-19	Lecknachweisflicken
GB0512249D0 (en)	2005-07-27	Hayfit3
ZA200708531B (en)	2009-02-25	Pyridylmethylsulfone derivative
IL184481A0 (en)	2007-10-31	Fluoroalkylpyrrolidine derivative